LATEST
Maximus Federal Services agreed to acquire Agile DefensenewMount Logan Management agreed to acquire Alternative Fund AdvisorsnewDime Commercial Bancshares / ES BancsharesnewSalesforce agreed to acquire BrazeJV Investors / Oro Mobility HoldingsMorgan Stanley Capital Partners acquired The Rapid GroupCBRE Group agreed to acquire Onnec GroupBevPoint Capital agreed to acquire ESGMarwynn Holdings acquired Zhituo SoftwareAspire-Lakewood Holding acquired Dura Driver Control SystemsTransom Signal MergerSub / SoundThinkingSilgan / Trivium: minority stake
Open App
Agreement signedAgreed 22 Jun 2023

Tourmaline Bio, Inc. /
Talaris Therapeutics, Inc.

Tourmaline Bio and Talaris Therapeutics enter into a merger agreement

Buy side: Tourmaline Bio, Inc.
Buy sideTourmaline Bio, Inc.
Target: Talaris Therapeutics, Inc.
TargetTalaris Therapeutics, Inc.
Source · 22 Jun 2023
See the source
Buy side: Tourmaline Bio, Inc.
Buy sideTourmaline Bio, Inc.
Target: Talaris Therapeutics, Inc.
TargetTalaris Therapeutics, Inc.
01 / BuyerTourmaline Bio, Inc.
02 / TargetTalaris Therapeutics, Inc.
01

What happened

Tourmaline Bio, Inc. agreed to combine with Talaris Therapeutics, Inc. through a reverse merger. The filing describes the merger agreement and related stockholder approvals.

Terms weren't disclosed.

02

The source

Everything on this page comes from the source below.

01
Source · Original source

Tourmaline Bio and Talaris Therapeutics enter into a merger agreement

This document is the source for the companies, stage and people on this page.

Original filingUnlock with Pro
03

Timeline

Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.

  1. Published by the source

    The source this page is built from.

The same firms, in other deals

The firms' deal history and connections across other deals.

These firms' full profiles are part of Pro.

Request accessAlready invited? Sign in

Carrywatch Pro is by invitation. An invite lets you buy Pro.